Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,405.63
(
0.06%
)
US TECH 100
28,376.40
(
0.31%
)
Dow Jones
49,617.86
(
-0.29%
)
Brent Oil
105.42
(
-0.33%
)
Bitcoin
79,673.64
(
-1.02%
)
News Focus
News Focus
Post# of 518345
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27835
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: hapit post# 157242

Wednesday, 07/11/2018 2:59:35 AM

Wednesday, July 11, 2018 2:59:35 AM

Post# of 518345
Missling has previously stated the company is navigating the shortest way to market through Rett.

It makes sense if he is still pursuing a route that can secure approval out of the P2 Orphan Drug Designation trial from a clear set of endpoints being met.

It may take some time worth spending.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News